This work is licensed under a Creative Commons Attribution 4.0 International License.
Arenicin-3 [Y5R,V8A,Y9S,V13L], NZ17125
General Information
DRACP ID DRACP02849
Peptide Name Arenicin-3 [Y5R,V8A,Y9S,V13L], NZ17125
Sequence GFCWRVCASRNGLRVCYRRCN
Sequence Length 21
UniProt ID A0A3F2YLM5
PubChem CID Not available
Origin Synthetic (Derived from Arenicin-3)
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| HepG2 | Hepatoblastoma | Blastoma | CC50=299 μg/ml | Resazurin assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: HC10= µg/ml
Normal (non-cancerous) Cytotoxicity HEK-293: CC50=250 µg/ml; HK-2: CC50=110 µg/ml
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys3<--->Cys20; Cys7<--->Cys16
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C105H167N39O26S4
Absent amino acids DEHIKMPQT
Common amino acids R
Mass 287688
Pl 9.72
Basic residues 5
Acidic residues 0
Hydrophobic residues 6
Net charge 5
Boman Index -6430
Hydrophobicity -30.95
Aliphatic Index 50.95
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 7240
Absorbance 280nm 362
Polar residues 10
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32576824
Title An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
Doi 10.1038/s41467-020-16950-x
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_17219
This work is licensed under a Creative Commons Attribution 4.0 International License.